Freddy A. Jimenez is SVP & GENERAL COUNSEL of Celldex Therapeutics, Inc.. Currently has a direct ownership of 35,464 shares of CLDX, which is worth approximately $891,564. The most recent transaction as insider was on Jun 05, 2024, when has been sold 9,540 shares (Common Stock) at a price of $10.38 per share, resulting in proceeds of $99,025. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.5K
0% 3M change
8147.44% 12M change
Total Value Held $891,564

Freddy A. Jimenez Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Exercise of conversion of derivative security
$99,025 $10.38 p/Share
9,540 Added 21.2%
35,464 Common Stock
Jun 03 2024
SELL
Open market or private sale
$269,001 $33.6 p/Share
8,006 Reduced 23.6%
25,924 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$83,102 $10.38 p/Share
8,006 Added 19.09%
33,930 Common Stock
Feb 13 2024
BUY
Exercise of conversion of derivative security
$142,579 $5.9 p/Share
24,166 Added 48.25%
25,924 Common Stock
Aug 11 2021
BUY
Open market or private purchase
$19,900 $46.28 p/Share
430 Added 50.0%
430 Common Stock
FAJ

Freddy A. Jimenez

SVP & GENERAL COUNSEL
Hampton, NJ

Track Institutional and Insider Activities on CLDX

Follow Celldex Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLDX shares.

Notify only if

Insider Trading

Get notified when an Celldex Therapeutics, Inc. insider buys or sells CLDX shares.

Notify only if

News

Receive news related to Celldex Therapeutics, Inc.

Track Activities on CLDX